BTIG Adds Bob Dentice to Healthcare Investment Banking Leadership Team

NEW YORK--(BUSINESS WIRE)--BTIG announced today that Bob Dentice has joined the firm as a Managing Director and Co-Head of Healthcare Investment Banking. Mr. Dentice will play a key role in advancing the group’s effort to provide innovative financial solutions and strategic advisory services for biopharmaceutical companies.

“Bob has a wealth of experience with a deep understanding of Healthcare and the Biotech sector,” said Jon Dever, Head of BTIG Investment Banking. “His expertise will position BTIG to offer even greater value to our clients in this critical area of growth for the firm.”

Mr. Dentice has more than 25 years of investment banking experience. Most recently, he was a Managing Director focused on the Biopharmaceutical sector at Cantor Fitzgerald. Previously, Mr. Dentice held senior positions at HSBC and CIBC World Markets. He has transactional expertise across equity, debt, M&A and restructuring.

BTIG’s Investment Banking team engages with clients and institutional investors on mergers and acquisitions, public offerings including IPOs and follow-on offerings, ATMs, SPACs, private placements and PIPEs, convertibles, debt and loans, buybacks, liquidity solutions, venture capital, and private equity transactions. BTIG’s Investment Banking expertise spans the consumer, energy, infrastructure and transportation, financial services, healthcare, industrials, aerospace and defense, real estate, technology, media, and telecommunications sectors. Aftermarket services include trading, corporate access, as well as proprietary research and strategy products.

About BTIG

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 700 employees, BTIG, LLC and its affiliates operate out of 20 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities. The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

Disclaimer: https://www.btig.com/disclaimer.aspx